This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duplan, S. M. Articles by Kenigsberg, R. L. Search for Related Content PubMed PubMed Citation Articles by Duplan, S. M. Articles by Kenigsberg, R. L.

Antitumor Activity of Fibroblast Growth Factors (FGFs) for Medulloblastoma May Correlate with FGF Receptor Expression and Tumor Variant¹

Developmental Neurobiology Group, Research Center, St. Justine’s Hospital, Montreal, Quebec, Canada H3T 1C5

Members of the fibroblast growth factor (FGF) family, which normally control cerebellar neuronal maturation, may represent more natural and less toxic tools with which to target medulloblastoma (MB), an embryonal brain tumor thought to arise from cerebellar neuronal precursors. In support of this, we found previously basic FGF/FGF-2 can inhibit MB progression by inducing neuronal-like differentiation, slowing the growth, and triggering apoptosis of a MB cell line we established from a histopathologically classic tumor (R. L. Kenigsberg et al., Am. J. Pathol., 151: 867–881, 1997). In the present study, the usefulness of this approach is additionally investigated. We report that of the five FGFs found in the developing cerebellum, only two, FGF-2 and FGF-9, possess antitumoral activity for MB. This activity is only noted for cell lines that originate from classic (UM-MB1 and SYR) rather than desmoplastic (HSJ) tumors. Whereas these FGFs inhibit proliferation of both classic cell lines, they only advance neuronal differentiation and induce apoptosis of one, UM-MB1. Consistent with these responses, after FGF treatment, levels of neurofilaments and the proapoptotic modulator Bax only increase in UM-MB1, whereas the cyclin-dependent kinase inhibitor p27/Kip1 (p27), which accumulates in cerebellar neuronal precursors before they exit the cell cycle, goes up in both UM-MB1 and SYR. Finally, although the histological variant of MB may help predict the sensitivity of MB to the FGFs, the selectivity, specificity, and type of response elicited may be dictated by, as evident by immunoprecipitation and Western blot analyses, the expression of certain FGF receptor types.

This article has been cited by other articles:

				M. P. Fogarty, B. A. Emmenegger, L. L. Grasfeder, T. G. Oliver, and R. J. Wechsler-Reya Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells PNAS, February 20, 2007; 104(8): 2973 - 2978. [Abstract] [Full Text] [PDF]

				M. Yi, R. Belcastro, S. Shek, D. Luo, M. Post, and A. K. Tanswell Fibroblast Growth Factor-2 and Receptor-1{alpha}(IIIc) Regulate Postnatal Rat Lung Cell Apoptosis Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 581 - 589. [Abstract] [Full Text] [PDF]

				Y. Li, B. Lal, S. Kwon, X. Fan, U. Saldanha, T. E. Reznik, E. B. Kuchner, C. Eberhart, J. Laterra, and R. Abounader The Scatter Factor/Hepatocyte Growth Factor: c-Met Pathway in Human Embryonal Central Nervous System Tumor Malignancy Cancer Res., October 15, 2005; 65(20): 9355 - 9362. [Abstract] [Full Text] [PDF]

				L.-M. Sturla, C. W. Cowan, L. Guenther, R. C. Castellino, J. Y.H. Kim, and S. L. Pomeroy A Novel Role for Extracellular Signal-Regulated Kinase 5 and Myocyte Enhancer Factor 2 in Medulloblastoma Cell Death Cancer Res., July 1, 2005; 65(13): 5683 - 5689. [Abstract] [Full Text] [PDF]